Collectively, these data suggest that leiomodin-1 antibodies are directly interacting with membranous leiomodin-1 in newly formed neurons to initiate a neurotoxic cascade and may thus be contributing to the development of epilepsy. Here, LMOD1 is linked to epilepsy.